[Insulin sensitivity in children aged 6 to 16 years: association with nutritional status and pubertal development]

Raquel Burrows A1, Laura Leiva B, Medardo Burgueño A

  • 1Instituto de Nutrición y Tecnología de los Alimentos, Universidad de Chile, José Pedro Alessandri 5540, Macul, Chile. rburrows@uec.inta.uchile.cl

Revista Medica De Chile
|February 6, 2007
PubMed

Insights

Childhood obesity is common in Chile. Insulin sensitivity (IS) decreases with puberty, with fasting insulin levels increasing by 50%, impacting hyperinsulinism and insulin resistance diagnosis.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Obesity Research

Context:

  • High prevalence of obesity and hyperinsulinism in Chilean prepuberal children.
  • Need for accurate assessment of insulin sensitivity (IS) in pediatric populations.
  • Evaluating metabolic health markers in relation to body composition and pubertal development.

Purpose:

  • To assess insulin sensitivity (IS) using fasting insulin, HOMA, and QUICKI in Chilean children.
  • To examine the correlation between IS markers and anthropometric measurements (BMI, %TBF, WC).
  • To investigate the influence of pubertal maturation on insulin sensitivity.

Summary:

  • Insulin sensitivity (IS) showed strong associations with total body fat percentage (%TBF) and waist circumference (WC).
  • Fasting insulin (Ins), HOMA, and QUICKI correlated significantly with BMI, %TBF, and WC.
  • Insulin levels and HOMA increased, while QUICKI decreased with age and puberty, indicating reduced IS.

Impact:

  • Confirms the link between IS, BMI, %TBF, WC, and pubertal development.
  • Highlights a significant decrease in IS and an approximate 50% increase in fasting insulin during puberty.
  • Emphasizes the importance of considering pubertal changes for diagnosing hyperinsulinism and insulin resistance in children.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...